Key result
Antihypertensive and lifestyle therapies preserve cardiac connexome function to prevent arrhythmias and heart failure.
Why the study?
Hypertension-induced remodeling promotes atrial and ventricular fibrillation, prompting an evaluation of hypertension-induced impairment of cardiomyocyte connexome junctions and the protective effects of treatment.
Do antihypertensive treatments and lifestyle interventions protect cardiac connexome function and prevent arrhythmias in hypertension?
Do antihypertensive treatments and lifestyle interventions protect cardiac connexome function and prevent arrhythmias in hypertension?
Protecting the cardiac connexome with antihypertensive drugs and lifestyle changes is a key mechanism for preventing hypertension-induced arrhythmogenic and structural heart disease.
Answers are grounded in this paper and cite their sources.
May support connexome preservation by antihypertensives and lifestyle interventions to reduce arrhythmias; extends mechanistic data but leaves open randomized confirmation.
Prolonged population aging and unhealthy lifestyles contribute to the progressive prevalence of arterial hypertension. This is accompanied by low-grade inflammation and over time results in heart dysfunction and failure. Hypertension-induced myocardial structural and ion channel remodeling facilitates the development of both atrial and ventricular fibrillation, and these increase the risk of stroke and sudden death. Herein, we elucidate hypertension-induced impairment of "connexome" cardiomyocyte junctions. This complex ensures cell-to-cell adhesion and coupling for electrical and molecular signal propagation. Connexome dysfunction can be a key factor in promoting the occurrence of both cardiac arrhythmias and heart failure. However, the available literature indicates that arterial hypertension treatment can hamper myocardial structural remodeling, hypertrophy and/or fibrosis, and preserve connexome function. This suggests the pleiotropic effects of antihypertensive agents, including anti-inflammatory. Therefore, further research is required to identify specific molecular targets and pathways that will protect connexomes, and it is also necessary to develop new approaches to maintain heart function in patients suffering from primary or pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Sýkora et al. (2023) conducted a review in Arterial hypertension and pulmonary arterial hypertension. Antihypertensive treatments and lifestyle interventions was evaluated. Antihypertensive agents, anti-inflammatory agents, and lifestyle interventions preserve cardiac connexome function and prevent hypertension-induced arrhythmias and heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: